Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
JCI Insight
|
November 7, 2024
Gpnmb and Spp1 mark a conserved macrophage injury response masking fibrosis-specific programming in the lung
Emily M King, Yifan Zhao, Camille M Moore, et al.
Chest
|
May 6, 2024
Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis
Christopher D Barrett, Peter K Moore, Ernest E Moore, et al.
Frontiers in Medicine
|
May 7, 2026
The ethics of blood stewardship and quantitative futility assessments to predict certain death in neurotrauma patients
Marie N Karam, Jenny Chen, Samuel J Thomas, et al.
The Journal of Trauma and Acute Care Surgery
|
June 16, 2026
Traumatic hemothorax activates complement, stimulates proinflammatory cytokine release, and primes neutrophils for local inflammatory reactive oxygen species production
Nicolle K Barmettler, Collin M White, Flobater I Gawargi, et al.
Journal of Clinical Medicine
|
February 27, 2026
Prevalence of Futility Protocols for Severely Bleeding Trauma Patients: A Survey from the Association for the Advancement of Blood & Biotherapies (AABB)
Samuel J Thomas, Dan A Waxman, Daniela Hermelin, et al.
The Journal of Trauma and Acute Care Surgery
|
June 11, 2025
Plasminogen supplementation improves lysis of inflammatory retained traumatic hemothorax
Elizabeth R Maginot, Flobater I Gawargi, Ernest E Moore, et al.
Research and Practice in Thrombosis and Haemostasis
|
March 28, 2022
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study
Christopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
Chest
|
September 30, 2021
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial
Christopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
JCI Insight
|
November 7, 2024
Gpnmb and Spp1 mark a conserved macrophage injury response masking fibrosis-specific programming in the lung
Emily M King, Yifan Zhao, Camille M Moore, et al.
Chest
|
May 6, 2024
Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis
Christopher D Barrett, Peter K Moore, Ernest E Moore, et al.
Frontiers in Medicine
|
May 7, 2026
The ethics of blood stewardship and quantitative futility assessments to predict certain death in neurotrauma patients
Marie N Karam, Jenny Chen, Samuel J Thomas, et al.
The Journal of Trauma and Acute Care Surgery
|
June 16, 2026
Traumatic hemothorax activates complement, stimulates proinflammatory cytokine release, and primes neutrophils for local inflammatory reactive oxygen species production
Nicolle K Barmettler, Collin M White, Flobater I Gawargi, et al.
Journal of Clinical Medicine
|
February 27, 2026
Prevalence of Futility Protocols for Severely Bleeding Trauma Patients: A Survey from the Association for the Advancement of Blood & Biotherapies (AABB)
Samuel J Thomas, Dan A Waxman, Daniela Hermelin, et al.
The Journal of Trauma and Acute Care Surgery
|
June 11, 2025
Plasminogen supplementation improves lysis of inflammatory retained traumatic hemothorax
Elizabeth R Maginot, Flobater I Gawargi, Ernest E Moore, et al.
Research and Practice in Thrombosis and Haemostasis
|
March 28, 2022
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study
Christopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
Chest
|
September 30, 2021
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial
Christopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
Page
of 4